During the 2019 pandemic sweeping through hospitals, an insidious companion emerged in bloodstream infections, where bacteria ...

The global clarithromycin market is projected to reach a valuation ... The European market is characterized by strong emphasis on antimicrobial resistance monitoring, rational antibiotic use ...

The class of antibiotics called macrolides have been used for decades to treat various bacterial infections. You can tell a macrolide antibiotic because they end in ‘–mycin’.

Antibiotics are medications that treat bacterial infections. They achieve this by killing bacteria or slowing their growth. Some common types of antibiotics include penicillin and macrolides ...

Interestingly, macrolide antibiotics and EM-523, both failed to induce bone regeneration in age-matched DEL-1-deficient mice, confirming that DEL-1 is crucial for the observed bone-regenerating ...

The global macrolide antibiotics market was valued at $5.6 billion in 2022 and is projected to reach $7.0 billion by 2032, registering a CAGR of 2.3% from 2023 to 2032. Macrolides represent a class of ...

The global macrolide antibiotics market was valued at $5.6 billion in 2022, and is projected to reach $7.0 billion by 2032, registering a CAGR of 2.3% from 2023 to 2032.

The global macrolide antibiotics market was valued at $5.6 billion in 2022, and is projected to reach $7.0 billion by 2032, registering a CAGR of 2.3% from 2023 to 2032. Allied_Market_Research_Logo ...

Compared with peers without SNHL, pediatric patients with SNHL were more likely to have received a macrolide prescription compared to a penicillin prescription (adjusted OR 1.31, 95% CI 1.05-1.64 ...